Sun Pharmaceutical Industries, incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 235134.83 Crore) operating in Pharmaceuticals sector.
Sun Pharmaceutical Industries key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2022.
Financials
For the quarter ended 31-03-2023, the company has reported a Consolidated Total Income of Rs 11303.95 Crore, down -.97 % from last quarter Total Income of Rs 11414.85 Crore and up 18.24 % from last year same quarter Total Income of Rs 9560.35 Crore. Company has reported net profit after tax of Rs 2016.78 Crore in latest quarter.
The company’s top management includes Mr.Israel Makov, Mr.Dilip S Shanghvi, Mr.Sailesh T Desai, Mr.Kalyanasundaram Subramanian, Mr.Sudhir V Valia, Dr.Pawan Goenka, Mr.Rama Bijapurkar, Mr.Gautam Doshi. Company has S R B C & Co. LLP as its auditors. As on 31-03-2023, the company has a total of 240 Crore shares outstanding.
Breakout above falling channel and price sustaining above 20 days EMA signaling continuation of up move.
Promoter/FII Holdings
Promoters held 54.48 per cent stake in the company as of 31-Mar-2023, while FIIs owned 16.88 per cent, DIIs 19.07 per cent.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price